Bridge Pharmaceuticals, Inc. Takes On China With $22M Series B

5/30/2006 - Bridge Pharmaceuticals Inc., a contract drug researcher looking to perform studies in greater China for biotech and pharmaceutical companies, has raised $22 million in Series B financing.

MORE ON THIS TOPIC